Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopy

被引:2
|
作者
Iinuma, Koji [1 ]
Yuhara, Kazuya [2 ]
Kotaka, Hiroto [2 ]
Ozawa, Kaori [2 ]
Kato, Daiki [1 ]
Takai, Manabu [1 ]
Nakane, Keita [1 ]
Mizutani, Kosuke [1 ]
Tsuchiya, Tomohiro [1 ]
Koie, Takuya [1 ]
机构
[1] Gifu Univ Grad, Sch Med, Dept Urol, 1-1 Yanagido, Gifu 5011194, Japan
[2] Japanese Red Cross Takayama Hosp, Dept Urol, Takayama, Japan
基金
日本学术振兴会;
关键词
carcinoma in situ; non‐ muscle‐ invasive bladder cancer; random biopsy; white light cystoscopy; TRANSITIONAL-CELL-CARCINOMA; PHOTODYNAMIC DIAGNOSIS; FOLLOW-UP; BTA TEST; RECURRENCE; MANAGEMENT; CYTOLOGY; METAANALYSIS; GUIDELINES; BIOPSIES;
D O I
10.1002/cnr2.1321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Although few studies evaluated the significance of random biopsies under white light cystoscopy (WLC) in patients with non-muscle-invasive bladder cancer (NMIBC), the findings are controversial. Aim This aim of this study was to evaluate what kind of preoperative covariates were useful as predictive factors in detecting carcinoma in situ (CIS) from normal-appearing mucosa using random bladder biopsies under WLC. Methods and Results A total of 229 patients with NMIBC underwent initial TUR followed by random biopsies under WLC at Red Cross Takayama Hospital between 2007 and 2016. These patients underwent TUR with complete resection of intravesical visible tumors followed by random biopsies of normal-appearing mucosa. In this study, random bladder biopsies of normal-appearing urothelial mucosa, excluding abnormal mucosa, were carried out with a cold punch in the selected intravesical sites. The covariates included age, gender, the urine cytology result, presence of an abnormal mucosa, number of tumors, size of the largest tumors, configuration of the tumor, and tumor type. Abnormal mucosa was defined as reddish or mossy areas at the time of TUR under WLC. The primary endpoint was to determine what kind of preoperative covariates were useful as predictive factors in detecting CIS from normal-appearing mucosa using random bladder biopsies under WLC. Finally, 212 patients were evaluated, and 67 patients (31.6%) were diagnosed with CIS from normal-appearing mucosa. In univariate analysis, positive urine cytology, abnormal mucosa, and the number of tumors were significantly associated with concomitant CIS. On multivariate analysis, positive urine cytology and abnormal mucosa were significantly associated with CIS. Conclusion The patients who were diagnosed with positive urine cytology or abnormal mucosa by WLC are ideal candidates for TUR followed by random biopsy of normal-appearing mucosa.
引用
收藏
页数:6
相关论文
共 20 条
  • [1] Predictive Factors for Residual Cancer in Second Transurethral Resection for Non-muscle-invasive Bladder Cancer
    Akitake, Masakazu
    Yamaguchi, Akito
    Shiota, Masaki
    Imada, Kenjiro
    Tatsugami, Katsunori
    Yokomizo, Akira
    Naito, Seiji
    Eto, Masatoshi
    ANTICANCER RESEARCH, 2019, 39 (08) : 4325 - 4328
  • [2] Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor
    Fujita, Naoki
    Hatakeyama, Shingo
    Momota, Masaki
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Ito, Hiroyuki
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoshikawa, Kazuaki
    Ohyama, Chikara
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (08) : 684.e1 - 684.e8
  • [3] Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review
    Maisch, Philipp
    Koziarz, Alex
    Vajgrt, Jon
    Narayan, Vikram
    Kim, Myung Ha
    Dahm, Philipp
    BJU INTERNATIONAL, 2022, 130 (06) : 730 - 740
  • [4] Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor
    Fujita, Naoki
    Hatakeyama, Shingo
    Momota, Masaki
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Ito, Hiroyuki
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoshikawa, Kazuaki
    Ohyama, Chikara
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (10) : 795.e9 - 795.e17
  • [5] Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer
    Lai, Lillian Y.
    Tafuri, Sean M.
    Ginier, Emily C.
    Herrel, Lindsey A.
    Dahm, Philipp
    Maisch, Philipp
    Lane, Giulia Ippolito
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (04):
  • [6] Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden
    Rose, James B.
    Armstrong, Shannon
    Hermann, Gregers G.
    Kjellberg, Jakob
    Malmstrom, Per-Uno
    BJU INTERNATIONAL, 2016, 117 (6B) : E102 - E113
  • [7] Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer
    Rolevich, Alexander I.
    Zhegalik, Alexander G.
    Mokhort, Andrey A.
    Minich, Alexander A.
    Vasilevich, Vladimir Yu.
    Polyakov, Sergey L.
    Krasny, Sergey A.
    Sukonko, Oleg G.
    WORLD JOURNAL OF UROLOGY, 2017, 35 (05) : 745 - 752
  • [8] Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non-muscle-invasive bladder cancer: A comparative study from experienced institutes
    Miyake, Makito
    Nishimura, Nobutaka
    Nakahama, Tomonori
    Nishimoto, Koshiro
    Oyama, Masafumi
    Matsushita, Yuto
    Miyake, Hideaki
    Fukuhara, Hideo
    Inoue, Keiji
    Kobayashi, Keita
    Matsumoto, Hiroaki
    Matsuyama, Hideyasu
    Fujii, Tomomi
    Hirao, Yoshihiko
    Fujimoto, Kiyohide
    BJUI COMPASS, 2023, 4 (03): : 305 - 313
  • [9] Green-light laser en bloc resection versus conventional transurethral resection for initial non-muscle-invasive bladder cancer: A randomized controlled trial
    Fan, Jinhai
    Wu, Kaijie
    Zhang, Nan
    Yang, Tao
    Liu, Nan
    Jiang, Yumei
    Bai, Xiaojing
    Wang, Xinyang
    He, Dalin
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (08) : 855 - 860
  • [10] VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: the 'CUT-less' Randomised Trial Protocol
    Del Giudice, Francesco
    Vestri, Annarita
    Fegatelli, Danilo Alunni
    Huesch, Tanja
    Belsey, Jonathan
    Nair, Rajesh
    Skinner, Eila C.
    Chung, Benjamin I.
    Pecoraro, Martina
    Sciarra, Alessandro
    Franco, Giorgio
    Pradere, Benjamin
    Gazzaniga, Paola
    Magloicca, Fabio Massimo
    Panebianco, Valeria
    De Berardinis, Ettore
    BJU INTERNATIONAL, 2025, 135 (02) : 346 - 354